Three ileus cases associated with the use of dipeptidyl peptidase‐4 inhibitors in diabetic patients

Dipeptidyl peptidase (DPP)‐4 inhibitors are a new class of antidiabetic drugs that increase incretin hormone levels to enhance blood sugar level‐dependent insulinotropic effects, suppress glucagon action, and reduce bowel motility. These incretin effects are ideal for blood sugar control. However, t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kanasaki, Keizo, Konishi, Kazunori, Hayashi, Ranji, Shiroeda, Hisakazu, Nomura, Tomoe, Nakagawa, Atsushi, Nagai, Takako, Takeda‐Watanabe, Ai, Ito, Hiroki, Tsuda, Shin‐ichi, Kitada, Munehiro, Fujii, Mizue, Kanasaki, Megumi, Nishizawa, Makoto, Nakano, Yasuharu, Tomita, Yasuto, Ueda, Nobuhiko, Kosaka, Takeo, Koya, Daisuke
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wiley-Blackwell 2013
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4020265/
https://ncbi.nlm.nih.gov/pubmed/24843724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12095
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge